Hot Life Science Investor Mandate 2: Early Stage VC Seeks Healthcare IT Opportunities

26 Nov

An early stage venture firm based in New York is investing from its third fund, which closed in 2013. The firm looks to invest in the Healthcare IT sector, and the initial investment size can range from $250k to $10million. The firm typically invests in companies at Seed and Series A stages.

The firm will consider companies across the US, and is currently looking for new opportunities in the Healthcare IT sectors. The firm will not consider devices or biotech companies. In the Healthcare IT sector, the firm is most interested in companies that do not need FDA approvals and focus on data, analytics, Internet, vertical applications and solutions. Historically, the firm was active in companies developing analytical platform, bioinformatics and software used in the pharmaceutical supply chain.

The firm primarily invests in pre-revenue companies, and prefers to invest in companies with a strong management team and significant growth potential.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: